OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic values of YTHDF1 regulated negatively by mir‐3436 in Glioma
Chenyang Xu, Bingjian Yuan, Tao He, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 13, pp. 7538-7549
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Hengyu Chen, Yuanhang Yu, Ming Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78

Interactions between m6A modification and miRNAs in malignant tumors
Xiao Han, Jing Guo, Zhipeng Fan
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 85

The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases
Zuyao Chen, Xiaolin Zhong, Min Xia, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 1270-1279
Open Access | Times Cited: 74

Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 59

Effects of writers, erasers and readers within miRNA‐related m6A modification in cancers
Huiru Feng, Xiaofei Yuan, Shuting Wu, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 39

Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents
Junya Lv, Lijuan Xing, Xin Zhong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114583-114583
Open Access | Times Cited: 24

The role of m6A modification in pediatric cancer
Yongping Chen, Lei Miao, Huiran Lin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188691-188691
Closed Access | Times Cited: 31

RNA m6Amethylation in cancer
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 30

The function and clinical implication of YTHDF1 in the human system development and cancer
Wenjun Ren, Yixiao Yuan, Yongwu Li, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 23

Genetic variants in m6A modification core genes are associated with glioma risk in Chinese children
Jing He, Yuan Li, Huiran Lin, et al.
Molecular Therapy — Oncolytics (2021) Vol. 20, pp. 199-208
Open Access | Times Cited: 36

Role of N6-methyladenosine methylation in glioma: recent insights and future directions
Chunlin Li, Bowen Li, Hui Wang, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12

The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4

RNA methylation in hematological malignancies and its interactions with other epigenetic modifications
Lan Yao, Hua Yin, Mei Hong, et al.
Leukemia (2021) Vol. 35, Iss. 5, pp. 1243-1257
Open Access | Times Cited: 27

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
Chao Sun, Xin Zheng, Yingxin Sun, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 26

m6A mRNA Modifications in Glioblastoma: Emerging Prognostic Biomarkers and Therapeutic Targets
Gloria S. Xie, Hope Richard
Cancers (2024) Vol. 16, Iss. 4, pp. 727-727
Open Access | Times Cited: 3

Decoding m6A mRNA methylation by reader proteins in cancer
Bing Han, Saisai Wei, Fengying Li, et al.
Cancer Letters (2021) Vol. 518, pp. 256-265
Closed Access | Times Cited: 20

The YTHDF1–TRAF6 pathway regulates the neuroinflammatory response and contributes to morphine tolerance and hyperalgesia in the periaqueductal gray
Handong Ouyang, Jianxing Zhang, Dongmei Chi, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 14

Insights into the regulatory role of RNA methylation modifications in glioma
Shengrong Long, Yu Yan, Hongyu Xu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8

The Significance of Circular RNA DDX17 in Prostate Cancer
Qi Lin, Jian Cai, Qin-Quan Wang
BioMed Research International (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 20

Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues
Qingren Meng, Heide Schatten, Qian Zhou, et al.
Aging (2023) Vol. 15, Iss. 13, pp. 6577-6619
Open Access | Times Cited: 7

Advances in brain epitranscriptomics research and translational opportunities
Feng Zhang, V. V. Ignatova, Guo‐li Ming, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 2, pp. 449-463
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top